Cypherpunk posted a $39.4M profit after a Zcash paper gain. The business still lost money.
A token gain saved the income line, but it did not fix the cash problem under the company.
CryptoVibe Desk · zcash · cypherpunk · earnings
- →Cypherpunk reported $39.4 million of Q2 net income after a reported $46 million unrealized ZEC gain.
- →The operating business still lost $4.7 million, so the quarter reads better than the company runs.
- →Watch Leap's funding path before year-end, because Phase 3 plans need cash or a transaction.
- ZEC → ZEC is the ticker for Zcash, a privacy-focused cryptocurrency.
- unrealized gain → An unrealized gain is a paper profit from an asset the company still holds and has not sold.
- Phase 3 → Phase 3 is a late drug trial that tests whether a treatment works safely in a larger group.
Cypherpunk posted $39.4 million of Q2 net income.
Per CryptoSlate, the number came after a reported $46 million unrealized gain on ZEC. The same report said Cypherpunk had a $4.7 million operating loss in the quarter. The tape matches the story: the coin mark did the work.
That matters because this is not a Zcash protocol story. It is a public-company accounting story. Token prices can move the income statement faster than the business can make cash.
As of June 30, Cypherpunk had $7.6 million in cash and cash equivalents. As of August 11, CryptoSlate reported the company held 323,394.38 ZEC at a $341.83 average purchase price. That position was 1.92% of circulating ZEC supply.
If you're reading the profit line first, slow down. Your bag is not the same thing as operating income. A paper gain can flip the quarter. It does not pay for a drug trial unless the company sells, borrows, or finds a deal.
That is where Leap Therapeutics enters. Cypherpunk said the Leap subsidiary is seeking resources to move sirexatamab into Phase 3 development. The company also said no financing or transaction is assured.
Protos framed the first half differently, citing a $37.8 million net loss for 2026's first six months. Both readings can be true. Q2 looked profitable because ZEC went up on the books. The operating and funding questions are still open.
The number to watch is not net income next quarter. It is cash, and whether Leap gets funded before the ZEC mark moves the other way.
Cypherpunk's choice to frame a ZEC-driven profit as the headline result looks thin while Leap still needs Phase 3 money and no financing is assured.
By December 31, 2026, watch whether Cypherpunk announces Leap financing or a transaction with named terms above $7.6 million.
Primary links and supporting reads used by the desk for this story.
Forward this.
